BRPI0311511A8 - "preparações farmacêuticas líquidas, e sua aplicação". - Google Patents

"preparações farmacêuticas líquidas, e sua aplicação".

Info

Publication number
BRPI0311511A8
BRPI0311511A8 BRPI0311511A BRPI0311511A BRPI0311511A8 BR PI0311511 A8 BRPI0311511 A8 BR PI0311511A8 BR PI0311511 A BRPI0311511 A BR PI0311511A BR PI0311511 A BRPI0311511 A BR PI0311511A BR PI0311511 A8 BRPI0311511 A8 BR PI0311511A8
Authority
BR
Brazil
Prior art keywords
pharmaceutical preparations
application
liquid pharmaceutical
thickener
oral application
Prior art date
Application number
BRPI0311511A
Other languages
English (en)
Inventor
Mertin Dirk
Edingloh Markus
Daube Gert
Original Assignee
Bayer Healthcare Ag
Bayer Animal Health Gmbh
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag, Bayer Animal Health Gmbh, Bayer Ip Gmbh filed Critical Bayer Healthcare Ag
Publication of BRPI0311511A publication Critical patent/BRPI0311511A/pt
Publication of BRPI0311511A8 publication Critical patent/BRPI0311511A8/pt
Publication of BRPI0311511B1 publication Critical patent/BRPI0311511B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PREPARAÇÕES FARMACÊUTICAS PARA A APLICAÇÃO ORAL CONTENDO RESINAS TROCADORAS DE ÍONS CARREGADAS COM SUBSTÂNCIA ATIVA BEM COMO FORMADORES DE GEL DE ESTRUTURA VISCOSA COMO ESPESSANTE". A presente invenção refere-se a preparações farmacêuticas para a aplicação oral, as quais contêm uma ou mais substâncias ativas, que são ligadas a um trocador de íons. Para o aperfeiçoamento da estabilidade física e da aceitância, especialmente nos animais, um formador de gel de estrutura viscosa está contido como espessante.
BRPI0311511-9A 2002-05-31 2003-05-19 "preparações farmacêuticas líquidas, e sua aplicação". BRPI0311511B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10224086A DE10224086A1 (de) 2002-05-31 2002-05-31 Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
DE10224086.8 2002-05-31
PCT/EP2003/005228 WO2003101422A2 (de) 2002-05-31 2003-05-19 Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker

Publications (3)

Publication Number Publication Date
BRPI0311511A BRPI0311511A (pt) 2005-02-22
BRPI0311511A8 true BRPI0311511A8 (pt) 2017-07-11
BRPI0311511B1 BRPI0311511B1 (pt) 2018-07-10

Family

ID=29432468

Family Applications (2)

Application Number Title Priority Date Filing Date
BR0311511-9A BR0311511A (pt) 2002-05-31 2003-05-19 Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante
BRPI0311511-9A BRPI0311511B1 (pt) 2002-05-31 2003-05-19 "preparações farmacêuticas líquidas, e sua aplicação".

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR0311511-9A BR0311511A (pt) 2002-05-31 2003-05-19 Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante

Country Status (28)

Country Link
US (1) US8545829B2 (pt)
EP (1) EP1513500B1 (pt)
JP (2) JP5350574B2 (pt)
KR (3) KR20120123607A (pt)
CN (1) CN1671361B (pt)
AR (2) AR039861A1 (pt)
AT (1) ATE421317T1 (pt)
AU (1) AU2003242545B2 (pt)
BR (2) BR0311511A (pt)
CA (1) CA2487648C (pt)
CR (1) CR7598A (pt)
DE (2) DE10224086A1 (pt)
DK (1) DK1513500T3 (pt)
ES (1) ES2319115T3 (pt)
HK (1) HK1083200A1 (pt)
HR (1) HRP20041219B1 (pt)
IL (2) IL165322A0 (pt)
MX (1) MXPA04011820A (pt)
MY (1) MY140953A (pt)
NO (1) NO333939B1 (pt)
PL (1) PL207269B1 (pt)
PT (1) PT1513500E (pt)
RU (1) RU2380091C2 (pt)
SI (1) SI1513500T1 (pt)
TW (1) TWI333422B (pt)
UA (1) UA84270C2 (pt)
WO (1) WO2003101422A2 (pt)
ZA (1) ZA200409616B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
EP1830851A2 (en) * 2004-12-06 2007-09-12 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
DE102005025900A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
US20070248564A1 (en) * 2006-04-25 2007-10-25 Roxane Laboratories, Inc. Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
CN101516334B (zh) 2006-09-26 2013-07-10 塔罗制药北美有限公司 用于抗生素的稳定组合物以及应用方法
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
WO2009120885A2 (en) * 2008-03-26 2009-10-01 Taro Pharmaceuticals U.S.A., Inc. Stabilizing lipid compositions for oral pharmaceutical agents
PT2544532T (pt) 2010-03-12 2017-06-02 Monsanto Technology Llc Composições de gel agroquímicas
US9918970B2 (en) * 2010-05-19 2018-03-20 Astellas Pharma Inc. Pharmaceutical composition comprising solifenacin
CN103957894A (zh) 2011-10-19 2014-07-30 R.P.谢勒技术有限公司 两相药物递送系统
FR2998305B1 (fr) * 2012-11-22 2015-02-20 Henkel Ag & Co Kgaa Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire
KR101697095B1 (ko) * 2015-09-30 2017-01-18 주식회사 포스코 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크
JP7410050B2 (ja) 2018-04-25 2024-01-09 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング キノロンカルボン酸エステルの加水分解プロセス
CN114249749B (zh) * 2022-01-08 2024-03-22 天象生物药业邢台有限责任公司 一种马波沙星甲酸盐的转化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60204713A (ja) * 1984-03-30 1985-10-16 Zenyaku Kogyo Kk 水性懸濁組成物
GB8618847D0 (en) 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5338732A (en) 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
DE69213954T2 (de) * 1991-10-28 1997-02-27 Procter & Gamble Verdicker/emulgatorsystem für getränke
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
BR9707606B1 (pt) * 1996-02-23 2010-08-10 ácidos 8-ciano-1-ciclopropil-7-(2,8-diazabiciclo(4.3.0) nonan-8-il)-6-flúor-1,4-diidro-4-oxo-3-quinolinocarbo xìlicos, bem como medicamentos que os compreendem.
US5980882A (en) 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE19854357A1 (de) 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
CZ302919B6 (cs) * 1999-07-14 2012-01-18 Schering-Plough Ltd. Vodný farmaceutický prostredek
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0020089D0 (en) 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10134719A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
US7001667B2 (en) * 2002-07-17 2006-02-21 Ppg Industries Ohio, Inc. Alkyd-based free radical wood coating compositions

Also Published As

Publication number Publication date
WO2003101422A3 (de) 2004-12-09
RU2004139022A (ru) 2005-07-10
CN1671361A (zh) 2005-09-21
JP2006503806A (ja) 2006-02-02
HRP20041219A2 (en) 2006-02-28
PL373456A1 (en) 2005-08-22
DE50311123D1 (de) 2009-03-12
DE10224086A1 (de) 2003-12-11
AR039861A1 (es) 2005-03-02
AU2003242545B2 (en) 2010-02-18
US20060177414A1 (en) 2006-08-10
RU2380091C2 (ru) 2010-01-27
US8545829B2 (en) 2013-10-01
SI1513500T1 (sl) 2009-06-30
MXPA04011820A (es) 2005-03-31
CR7598A (es) 2008-07-31
CA2487648A1 (en) 2003-12-11
KR101258373B1 (ko) 2013-04-30
KR20120006092A (ko) 2012-01-17
UA84270C2 (ru) 2008-10-10
CA2487648C (en) 2012-03-13
PT1513500E (pt) 2009-04-02
HK1083200A1 (en) 2006-06-30
ZA200409616B (en) 2006-05-31
ATE421317T1 (de) 2009-02-15
BR0311511A (pt) 2005-02-22
IL165322A0 (en) 2006-01-15
AU2003242545A1 (en) 2003-12-19
NO333939B1 (no) 2013-10-28
EP1513500B1 (de) 2009-01-21
MY140953A (en) 2010-02-12
EP1513500A2 (de) 2005-03-16
AR105798A2 (es) 2017-11-08
JP2011012087A (ja) 2011-01-20
WO2003101422A2 (de) 2003-12-11
JP5350574B2 (ja) 2013-11-27
HRP20041219B1 (hr) 2013-05-31
TW200406230A (en) 2004-05-01
PL207269B1 (pl) 2010-11-30
BRPI0311511A (pt) 2005-02-22
KR20050010015A (ko) 2005-01-26
BRPI0311511B1 (pt) 2018-07-10
IL165322A (en) 2015-11-30
DK1513500T3 (da) 2009-05-11
NO20045700L (no) 2004-12-29
ES2319115T3 (es) 2009-05-04
CN1671361B (zh) 2010-05-12
TWI333422B (en) 2010-11-21
KR20120123607A (ko) 2012-11-08

Similar Documents

Publication Publication Date Title
BRPI0311511A8 (pt) "preparações farmacêuticas líquidas, e sua aplicação".
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
BRPI0411982A (pt) glicano de aperfeiçoamento de terapia
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
BR0114927A (pt) Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BR9910113A (pt) Composições oftálmicas que se transformam em gel, contendo goma xantano
ATE163540T1 (de) Retinoid enthaltende, wässrige, gelartige darreichungsform
DK0739197T3 (da) Konserverede oftalmiske lægemiddelpræparater, som indeholder polymere kvaternære ammoniumforbindelser
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BR9915247A (pt) Compostos biaromáticos análogos da vitamina d,seus usos, composição farmacêutica e composiçãocosmética contendo os mesmos, e uso dacomposição cosmética
BR9803300A (pt) Formulação farmacêutica.
BR0114092A (pt) Guanididas de ácido cinámico substituìdas, processos para a sua preparação, sua aplicação como medicamento bem como o medicamento contendo as mesmas
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
BR0014946A (pt) Uso de dipiridamol ou mopidamol na fabricação de um medicamento para o tratamento e prevenção de distúrbios da microcirculação dependentes da fibrina
DE69718734T2 (de) Bicyclisch-aromatische Verbindungen
FR2744452B1 (fr) Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
ES2187125T3 (es) Compuestos biciclicos-aromaticos y su utilizacion en medicina humana o veterinaria asi como en cosmetologia.
ES2103116T3 (es) Nuevos compuestos bi-aromaticos derivados de amida, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BRPI0611526A2 (pt) composição tópica contendo gelatina
BR0211149A (pt) Preparados farmacêuticos contendo resinas trocadoras de ìons carregadas com substância ativa
RS51307B (sr) Farmaceutski sastav u obliku hidrogela za transdermalnu aplikaciju aktivnih materija
BRPI0409790A (pt) 7-azaindóis e seu uso como terapêuticos

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved